During the past decade, Ospendale S. Andrea EST conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospendale S. Andrea EST" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Ospendale S. Andrea EST" in a lesser frequency.

Most popular intervention types in "Ospendale S. Andrea EST" are "Drug" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (2 trials), "adjuvant therapy" (1 trials), "bevacizumab" (1 trials), "cisplatin" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospendale S. Andrea EST" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospendale S. Andrea EST". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospendale S. Andrea EST, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospendale S. Andrea EST, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".